An underground economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Popularity Online
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to message these profiles privately for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Separately, a robust trade exists on messaging services, where groups with thousands of members share comparison images, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Experts Voice Worries
Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.
Several experts stated the popularity for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Response and Content Elimination
Based on the social media company, the platform has taken down violative content and banned associated keywords and search suggestions. The company said it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.
Online Trading Activities
Research also discovered groups with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, populated with photos of weight loss, positive reviews and detailed instructions for preparing or injecting at home.
After moments of joining one group, a vendor posted contact information, where most transactions occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, health issues or previous experience.
Item Details and Pricing
Inside these communities, messages show black plastic parcels with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with purified liquid, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When asked how much time a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A representative for Telegram stated it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting substances they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.
Her staff has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly significant medical dangers”.
